Research

Our highlighted selection of Covid-related case series or case reports from the scientific press for Febuary 2023.

Our February Paper of the Month is a narrative review focusing on epidemiology, pathophysiology and treatment of secondary headache following SARS-COV-2 infection and vaccination, and on the impact of COVID-19 pandemic on primary headache disorders.

Our paper of the month is a retrospective nationwide cohort study that was carried out to determine the clinical sequelae of long covid for a year after infection in patients with mild disease, and to evaluate its association with age, sex, SARS-CoV-2 variants, and vaccination status.

Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2023.

Our highlighted selection of recent Covid-related case series or case reports from the scientific press for January 2023.

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for January 2023.

Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy.

Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year.

This recent EAN-funded study investigates the prevalence of burnout profiles and their contributing factors in European neurology residents, junior neurologists, and research fellows.

Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for December 2022.

Our pick of COVID-19-related cross-sectional case control studies from the scientific press for December 2022.

In order to support and develop expertise in bridging the gap between neuroscience and clinical knowledge the EAN Board has created a Scientific Panel on Neuroscience/Translational Neurology.

Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.

Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people.

A new publication in the European Journal of Neurology describes the process of developing and launching the EAN guideline prioritisation procedure.